Epistasis and Pleiotropy Affect the Modularity of the Genotype-Phenotype Map of Cross-Resistance in HIV-1

被引:12
|
作者
Polster, Robert [1 ]
Petropoulos, Christos J. [2 ]
Bonhoeffer, Sebastian [1 ]
Guillaume, Frederic [1 ,3 ]
机构
[1] Swiss Fed Inst Technol, Inst Integrat Biol, Univ Str 16, Zurich, Switzerland
[2] Monogram Biosci, San Francisco, CA USA
[3] Univ Zurich, Dept Evolutionary Biol & Environm Studies, Zurich, Switzerland
基金
瑞士国家科学基金会;
关键词
mutation; genetic integration; M-matrix; G-matrix; IMMUNODEFICIENCY-VIRUS TYPE-1; REVERSE-TRANSCRIPTASE; GENETIC ARCHITECTURE; DROSOPHILA-MELANOGASTER; DIFFERENTIAL EPISTASIS; CAENORHABDITIS-ELEGANS; MANDIBULAR MORPHOLOGY; QUANTITATIVE TRAITS; DRUG-RESISTANCE; COMPLEX TRAITS;
D O I
10.1093/molbev/msw206
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The genotype-phenotype (GP) map is a central concept in evolutionary biology as it describes the mapping of molecular genetic variation onto phenotypic trait variation. Our understanding of that mapping remains partial, especially when trying to link functional clustering of pleiotropic gene effects with patterns of phenotypic trait co-variation. Only on rare occasions have studies been able to fully explore that link and tend to show poor correspondence between modular structures within the GP map and among phenotypes. By dissecting the structure of the GP map of the replicative capacity of HIV-1 in 15 drug environments, we provide a detailed view of that mapping from mutational pleiotropic variation to phenotypic co-variation, including epistatic effects of a set of amino-acid substitutions in the reverse transcriptase and protease genes. We show that epistasis increases the pleiotropic degree of single mutations and provides modularity to the GP map of drug resistance in HIV-1. Moreover, modules of epistatic pleiotropic effects within the GP map match the phenotypic modules of correlated replicative capacity among drug classes. Epistasis thus increases the evolvability of cross-resistance in HIV by providing more drug-and class-specific pleiotropic profiles to the main effects of the mutations. We discuss the implications for the evolution of cross-resistance in HIV.
引用
收藏
页码:3213 / 3225
页数:13
相关论文
共 50 条
  • [41] Resistance profile and cross-resistance of HIV-1 among patients failing a non-nucleoside reverse transcriptase inhibitor-containing regimen
    Delaugerre, C
    Rohban, R
    Simon, A
    Mouroux, M
    Tricot, C
    Agher, R
    Huraux, JM
    Katlama, C
    Calvez, V
    JOURNAL OF MEDICAL VIROLOGY, 2001, 65 (03) : 445 - 448
  • [42] Exploiting HIV-1 protease and reverse transcriptase cross-resistance information for improved drug resistance prediction by means of multi-label classification
    Riemenschneider, Mona
    Senge, Robin
    Neumann, Ursula
    Huellermeier, Eyke
    Heider, Dominik
    BIODATA MINING, 2016, 9
  • [43] Exploiting HIV-1 protease and reverse transcriptase cross-resistance information for improved drug resistance prediction by means of multi-label classification
    Mona Riemenschneider
    Robin Senge
    Ursula Neumann
    Eyke Hüllermeier
    Dominik Heider
    BioData Mining, 9
  • [44] Predominance of positive epistasis among drug resistance-associated mutations in HIV-1 protease
    Zhang, Tian-hao
    Dai, Lei
    Barton, John P.
    Du, Yushen
    Tan, Yuxiang
    Pang, Wenwen
    Chakraborty, Arup K.
    Lloyd-Smith, James O.
    Sun, Ren
    PLOS GENETICS, 2020, 16 (10):
  • [45] Cross-resistance patterns for HIV-1 multi-nucleoside resistant mutants with mutations associated with re-sensitization to zidovudine
    Lennerstrand, J
    Bergroth, T
    Shao, XW
    Van Cauwenberge, A
    Mc Kenna, P
    Sönnerborg, A
    ANTIVIRAL THERAPY, 2002, 7 : S43 - S43
  • [46] Combinatorial CRISPR-Cas9 and RNA Interference Attack on HIV-1 DNA and RNA Can Lead to Cross-Resistance
    Zhao, Na
    Wang, Gang
    Das, Atze T.
    Berkhout, Ben
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2017, 61 (12)
  • [47] Characterizing the relationship between HIV-1 genotype and phenotype: Prediction-based classification
    Foulkes, AS
    De Gruttola, V
    BIOMETRICS, 2002, 58 (01) : 145 - 156
  • [48] Selection of nonnucleoside reverse transcriptase inhibitor-associated mutations in HIV-1 subtype C: evidence of etravirine cross-resistance
    Neogi, Ujjwal
    Shet, Anita
    Shamsundar, Ranjani
    Ekstrand, Maria L.
    AIDS, 2011, 25 (08) : 1123 - 1126
  • [49] Examination of wide variation in replication capacity of wild-type HIV-1: analysis of genotype-phenotype association via tree-structured methods
    Barbour, JD
    Wrin, T
    Deeks, S
    Hecht, FM
    Hellmann, NS
    Petropoulos, CJ
    Grant, RM
    Segal, MR
    ANTIVIRAL THERAPY, 2003, 8 (03) : U93 - U93
  • [50] Correlation between interpreted genotype and VirtualPhenotype for predicting drug resistance in HIV-1
    Gallego, O
    Martín-Carbonero, L
    de Mendoza, C
    Corral, A
    Soriano, V
    ANTIVIRAL THERAPY, 2003, 8 (03) : U99 - U100